Communiqués Integrated BioPharma, Inc.

Actions

INBP

US45811V1052

Temps Différé OTC Markets Autres places de cotation 20:08:43 24/06/2024			Varia. 5j.	Varia. 1 janv.
0,2 ^USD	-10,38 %		-10,39 %	-18,43 %

10/05	Integrated BioPharma, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 mars 2024	CI
12/02	Integrated BioPharma, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024	13/05	AQ
INTEGRATED BIOPHARMA INC : Other Events, Financial Statements and Exhibits (form 8-K)	21/03/23	AQ
INTEGRATED BIOPHARMA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/02/23	AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/02/23	AQ
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K	28/11/22	PU
INTEGRATED BIOPHARMA INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	28/11/22	AQ
INTEGRATED BIOPHARMA INC Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K/A)	14/11/22	AQ
INTEGRATED BIOPHARMA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	14/11/22	AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/11/22	AQ
INTEGRATED BIOPHARMA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	24/10/22	AQ
INTEGRATED BIOPHARMA INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	14/09/22	AQ
INTEGRATED BIOPHARMA INC Management's Discussion and Analysis of Financial Condition and Results of Operations (dollars in thousands). (form 10-K)	13/09/22	AQ
INTEGRATED BIOPHARMA INC : Termination of a Material Definitive Agreement (form 8-K)	15/07/22	AQ
Integrated BioPharma : Announces Change in Directors - Form 8-K	21/06/22	PU
INTEGRATED BIOPHARMA INC : Financial Statements and Exhibits (form 8-K)	21/06/22	AQ
INTEGRATED BIOPHARMA INC : Results of Operations and Financial Condition, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibits (form 8-K)	12/05/22	AQ
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	12/05/22	AQ
Integrated BioPharma : Reports Results for its Quarter Ended December 31, 2022 - Form 8-K	10/02/22	PU
INTEGRATED BIOPHARMA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANICAL CONDITION AND RESULTS OF OPERATION (dollars in thousands) (form 10-Q)	10/02/22	AQ
Integrated BioPharma : Submission of Matters to a Vote of Security Holders - Form 8-K	29/11/21	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Integrated BioPharma, Inc.

Actions

INBP

US45811V1052

Communiqués

Filtres